Nevro Corp NVRO:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/03/24 EDT
11.29quote price arrow up+0.14 (+1.26%)
Volume
336,760
52 week range
10.27 - 28.89
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close11.29
  • 52 Week High28.89
  • 52 Week High Date05/15/23
  • 52 Week Low10.27
  • 52 Week Low Date05/01/24

Key Stats

  • Market Cap414.133M
  • Shares Out36.68M
  • 10 Day Average Volume0.69M
  • Dividend-
  • Dividend Yield-
  • Beta0.98
  • YTD % Change-47.54

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close11.29
  • 52 Week High28.89
  • 52 Week High Date05/15/23
  • 52 Week Low10.27
  • 52 Week Low Date05/01/24
  • Market Cap414.133M
  • Shares Out36.68M
  • 10 Day Average Volume0.69M
  • Dividend-
  • Dividend Yield-
  • Beta0.98
  • YTD % Change-47.54

RATIOS/PROFITABILITY

  • EPS (TTM)-2.57
  • P/E (TTM)-4.39
  • Fwd P/E (NTM)-4.24
  • EBITDA (TTM)-90.158M
  • ROE (TTM)-29.89%
  • Revenue (TTM)425.174M
  • Gross Margin (TTM)68.22%
  • Net Margin (TTM)-21.69%
  • Debt To Equity (MRQ)72.14%

EVENTS

  • Earnings Date05/07/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Nevro Corp

 

Profile

MORE
Nevro Corp. is a global medical device company. The Company is focused on delivering solutions that continue to set the standard for enduring patient outcomes in chronic pain treatment. Its comprehensive HFX spinal cord stimulation 3 (SCS) platform includes the Senza SCS system and support services for the treatment of chronic pain of the trunk and limb and painful diabetic neuropathy. It has developed and commercialized its HFX spinal cord stimulation (SCS) platform, which...
D. Keith Grossman
Executive Chairman of the Board
Kevin Thornal
President, Chief Executive Officer, Director
Roderick Macleod
Chief Financial Officer, Senior Vice President
Address
1800 Bridge Parkway
Redwood City, CA
94065
United States

Top Peers

SYMBOLLASTCHG%CHG
OSUR
OraSure Technologies Inc
5.49+0.01+0.18%
ARAY
Accuray Inc
1.62+0.08+5.19%
BVS
Bioventus Inc
3.97+0.01+0.25%
ATRC
AtriCure Inc
20.89-1.33-5.99%
AORT
Artivion Inc
20.93+0.38+1.85%